CPhI Worldwide 2025 to Convene in Frankfurt, Spotlighting Global Pharmaceutical Innovation
By Thomas Yuan

FRANKFURT — The world’s premier pharmaceutical ingredient exhibition, CPhI Worldwide 2025, will be held from October 28 to 30 at the Congress Centre Frankfurt, located at Ludwig-Erhard-Anlage 1, 60327 Frankfurt am Main, Germany. Organized by Informa Markets, the event is expected to draw thousands of global professionals across the biopharmaceutical, medical technology, and health product sectors.

Since its launch in 1990, CPhI Worldwide has evolved into the most influential platform for sourcing active pharmaceutical ingredients (APIs), exploring innovative drug formulations, and networking across the international medical supply chain. This year’s edition continues the tradition of excellence, offering a comprehensive showcase of breakthrough technologies and next-generation therapeutics.

Diverse Product Categories Covering the Full Pharma Spectrum

The exhibition will feature a wide array of products and services, spanning the entire pharmaceutical ecosystem:

• APIs: Including vitamins, hormones, analgesics, sulfonamides, tetracyclines, amino acids and derivatives, and digestive system drugs, as well as anti-infective treatments and chloramphenicols.

• Excipients & Formulations: Key components such as glidants, enteric coating materials, and other vital pharmaceutical excipients will be prominently featured.

• Natural Extracts: From plant and animal extracts to traditional Chinese medicine ingredients, functional food compounds, and nutraceuticals, exhibitors will highlight bio-based innovations in health products.

• Biotech Products & Reagents: Including cutting-edge solutions in antibodies, nucleic acid synthesis, cell biology assays, and biochemical reagents for applications across medical research, diagnostics, and therapeutic development.

• Technical Services: Encompassing molecular biology, microbiology, biochip analysis, instrument maintenance, and custom research outsourcing, these services cater to a wide range of R&D needs in modern drug discovery.

A Hub for Global Industry Collaboration

As pharmaceutical innovation accelerates worldwide, CPhI 2025 serves as a critical venue for companies seeking to expand their presence across Europe, Asia, and North America. From scaling up biotechnology manufacturing to sourcing high-quality medical supplies, attendees will engage in strategic dialogues, licensing opportunities, and cross-border partnerships.

CPhI Worldwide’s growing emphasis on sustainable pharmaceutical development, AI-driven R&D platforms, and supply chain resilience reflects the broader transformation of the life sciences industry in the post-pandemic era.

The event is expected to draw leading manufacturers, researchers, and distributors focused on chronic disease therapies, preventive health, and next-generation biologics, making it a must-attend for professionals across the medical technology, nursing supply, and healthcare logistics sectors.

With over three decades of global leadership, CPhI continues to raise the bar for innovation, standardization, and cross-border cooperation in pharmaceutical science.